Literature DB >> 20392458

Total anomalous pulmonary venous connection: results of surgical repair of 100 patients at a single institution.

Angela M Kelle1, Carl L Backer, Jeffrey G Gossett, Sunjay Kaushal, Constantine Mavroudis.   

Abstract

OBJECTIVE: Surgical repair of total anomalous pulmonary venous connection is associated with significant mortality and morbidity, especially in patients with single-ventricle physiology. This study analyzes total anomalous pulmonary venous connection surgical repair results at one institution to identify trends and indicators of positive outcome.
METHODS: Our cardiac surgery database identified 100 patients undergoing surgical repair of total anomalous pulmonary venous connection (1990-2008): supracardiac (52), cardiac (15), infracardiac (23), and mixed (10). The median age at repair was 14.6 days (range, 0-4 years), and the median weight was 3.5 kg (range, 1.3-15 kg). Patients were divided into 2 groups: biventricular (n = 83) or single-ventricle (n = 17) physiology. All but 1 of the patients with single-ventricle physiology had heterotaxy syndrome (94%), and 13 of 17 patients had supracardiac anatomy.
RESULTS: There were 12 operative deaths (4 in the biventricular group [5%] and 8 in the single-ventricle group [47%], P < .01) and 9 late deaths (6 in the biventricular group [7%] and 3 in the single-ventricle group [18%], P < .05). Death by total anomalous pulmonary venous connection type was supracardiac (12/52; 23.1%), cardiac (1/15; 6.7%), infracardiac (3/23; 13.0%), and mixed (5/10; 50%). Pulmonary venous obstruction was present in 22 patients in the biventricular group (27%) and in 7 patients in the single-ventricle group (41%; P = .25). Mortality was 9 of 29 (31%) in those with pulmonary venous obstruction and 12 of 71 (17%) in those with nonpulmonary venous obstruction (P = .23). Deep hypothermic circulatory arrest was used in 38 patients (27 in the biventricular group, 32.5%; 11 in the single-ventricle group, 64.7%). Mean deep hypothermic circulatory arrest time was 31.4 +/- 10.7 minutes (P = not significant between groups). Median postoperative length of stay was 11 days (range, 0-281 days). Nineteen patients required reoperation for pulmonary venous stenosis (14 in the biventricular group and 5 in the single-ventricle group. P = .045); the median time to reoperation was 104 days (range, 4-753 days).
CONCLUSION: Patients with total anomalous pulmonary venous connection with biventricular anatomy have good outcomes. Patients with single-ventricle anatomy have higher mortality and increased risk for pulmonary vein stenosis requiring reoperation. Mortality is highest in patients with mixed-type total anomalous pulmonary venous connection. Copyright 2010. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20392458     DOI: 10.1016/j.jtcvs.2010.02.024

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Total anomalous pulmonary venous drainage repair: redefining the long-term expectations.

Authors:  Matthew S Yong; Michael Z L Zhu; Igor E Konstantinov
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Repair of Total Anomalous Pulmonary Venous Connection: Risk Factors for Postoperative Obstruction.

Authors:  Brian R White; Deborah Y Ho; Jennifer A Faerber; Hannah Katcoff; Andrew C Glatz; Christopher E Mascio; Paul Stephens; Meryl S Cohen
Journal:  Ann Thorac Surg       Date:  2019-03-16       Impact factor: 4.330

Review 3.  Current topics in surgery for isolated total anomalous pulmonary venous connection.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Hayato Obi
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

4.  Management of pulmonary venous obstruction.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Toshio Doi; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Saori Nagura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-03

5.  Individual Pulmonary Veins Outgrow Somatic Growth After Primary Sutureless Repair for Total Anomalous Pulmonary Venous Drainage.

Authors:  Hyun-Jin Jung; Ji Hyun Bang; Chun-Soo Park; Jeong-Jun Park; Yu-Mi Im; Tae-Jin Yun
Journal:  Pediatr Cardiol       Date:  2015-10-03       Impact factor: 1.655

6.  Assessment of pulmonary veins after atrio-pericardial anastomosis by cardiovascular magnetic resonance.

Authors:  Steven C Greenway; Shi-Joon Yoo; Giedrius Baliulis; Christopher Caldarone; John Coles; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2011-11-21       Impact factor: 5.364

Review 7.  Surgery for total anomalous pulmonary venous connection: primary sutureless repair vs. conventional repair.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Toshio Doi; Katsunori Takeuchi; Shigeyuki Yamashita; Takahiro Homma; Shigeki Yokoyama; Masaya Aoki; Yuki Ikeno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-03-22

8.  Intrinsic obstruction in pulmonary venous drainage pathway is associated with poor surgical outcomes in patients with total anomalous pulmonary venous connection.

Authors:  Takaya Hoashi; Koji Kagisaki; Kenichi Kurosaki; Masataka Kitano; Isao Shiraishi; Hajime Ichikawa
Journal:  Pediatr Cardiol       Date:  2014-10-02       Impact factor: 1.655

9.  Modification of hemi-Fontan operation for patients with functional single ventricle and anomalous pulmonary venous connection to the superior vena cava: mid-term results.

Authors:  Hiroki Ito; Masaya Murata; Yujiro Ide; Mikio Sugano; Kazuyoshi Kanno; Kenta Imai; Motonori Ishido; Ryohei Fukuba; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-08

10.  Neurocognitive outcomes at kindergarten entry after surgical repair of total anomalous pulmonary venous connection in early infancy.

Authors:  Jonathan P Duff; Ari R Joffe; Shabnam Vatanpour; Diane M Moddemann; Charlene M T Robertson; Gwen Alton; Irina Dinu; David Ross; Ivan M Rebeyka
Journal:  Pediatr Cardiol       Date:  2014-09-11       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.